So nine MONTHS ago -- three YEARS into his calmare "trial" -- Loprinzi starts a study to determine the effectiveness of pregabalin -- an anti-convulsant -- on neuropathic pain due to chemo? Gee! Guess old calmare wasn't getting those 90 plus per cent success rates that MISTER Marineo was getting, huh?
And look! That one is an honest to gosh blinded, randomized, and controlled trial! Of course, that means that if it's successful, third party reinsurers will actually consider it WORTHWHILE in making in making decisions whether to pay for it!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.